126 related articles for article (PubMed ID: 35228699)
1. Mapping the mediators of Alzheimer's disease.
O'Leary K
Nat Med; 2022 Feb; ():. PubMed ID: 35228699
[No Abstract] [Full Text] [Related]
2. The Role of Mast Cells in Alzheimer's Disease.
Shaik-Dasthagirisaheb YB; Conti P
Adv Clin Exp Med; 2016; 25(4):781-7. PubMed ID: 27629855
[TBL] [Abstract][Full Text] [Related]
3. An update on the interactions between Alzheimer's disease, autophagy and inflammation.
Bostancıklıoğlu M
Gene; 2019 Jul; 705():157-166. PubMed ID: 31029603
[TBL] [Abstract][Full Text] [Related]
4. Association of plasma and CSF cytochrome P450, soluble epoxide hydrolase, and ethanolamide metabolism with Alzheimer's disease.
Borkowski K; Pedersen TL; Seyfried NT; Lah JJ; Levey AI; Hales CM; Dammer EB; Blach C; Louie G; Kaddurah-Daouk R; Newman JW;
Alzheimers Res Ther; 2021 Sep; 13(1):149. PubMed ID: 34488866
[TBL] [Abstract][Full Text] [Related]
5. The contribution of statistical parametric mapping in the assessment of precuneal and medial temporal lobe perfusion by 99mTc-HMPAO SPECT in mild Alzheimer's and Lewy body dementia.
Kemp PM; Hoffmann SA; Holmes C; Bolt L; Ward T; Holmes RB; Fleming JS
Nucl Med Commun; 2005 Dec; 26(12):1099-106. PubMed ID: 16264357
[TBL] [Abstract][Full Text] [Related]
6. Induction of immune system mediators in the hippocampal formation in Alzheimer's and Parkinson's diseases: selective effects on specific interleukins and interleukin receptors.
Araujo DM; Lapchak PA
Neuroscience; 1994 Aug; 61(4):745-54. PubMed ID: 7838374
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular brain impulses in Alzheimer's disease.
Rajna Z; Mattila H; Huotari N; Tuovinen T; Krüger J; Holst SC; Korhonen V; Remes AM; Seppänen T; Hennig J; Nedergaard M; Kiviniemi V
Brain; 2021 Aug; 144(7):2214-2226. PubMed ID: 33787890
[TBL] [Abstract][Full Text] [Related]
8. Hippocampal morphometry in population-based incident Alzheimer's disease and vascular dementia: the HAAS.
Scher AI; Xu Y; Korf ES; Hartley SW; Witter MP; Scheltens P; White LR; Thompson PM; Toga AW; Valentino DJ; Launer LJ
J Neurol Neurosurg Psychiatry; 2011 Apr; 82(4):373-6. PubMed ID: 20826877
[TBL] [Abstract][Full Text] [Related]
9. [The possible suppression of Alzheimer's disease by nonsteroidal anti-inflammatory drugs].
de Jong D; Jansen RW; Verbeek MM; Kremer HP
Ned Tijdschr Geneeskd; 2002 Nov; 146(44):2074-8. PubMed ID: 12448960
[TBL] [Abstract][Full Text] [Related]
10. Role of vascular risk factors and vascular dysfunction in Alzheimer's disease.
Dickstein DL; Walsh J; Brautigam H; Stockton SD; Gandy S; Hof PR
Mt Sinai J Med; 2010; 77(1):82-102. PubMed ID: 20101718
[TBL] [Abstract][Full Text] [Related]
11. Increased concentrations of homocysteine and asymmetric dimethylarginine and decreased concentrations of nitric oxide in the plasma of patients with Alzheimer's disease.
Selley ML
Neurobiol Aging; 2003 Nov; 24(7):903-7. PubMed ID: 12928048
[TBL] [Abstract][Full Text] [Related]
12. Cytoarchitectonic Mapping of MRI Detects Rapid Changes in Alzheimer's Disease.
Blair JC; Lasiecka ZM; Patrie J; Barrett MJ; Druzgal TJ
Front Neurol; 2020; 11():241. PubMed ID: 32425868
[TBL] [Abstract][Full Text] [Related]
13. Vascular aspects in Alzheimer's disease.
Skoog I
J Neural Transm Suppl; 2000; 59():37-43. PubMed ID: 10961416
[TBL] [Abstract][Full Text] [Related]
14. Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's Coordinating Centre.
Toledo JB; Arnold SE; Raible K; Brettschneider J; Xie SX; Grossman M; Monsell SE; Kukull WA; Trojanowski JQ
Brain; 2013 Sep; 136(Pt 9):2697-706. PubMed ID: 23842566
[TBL] [Abstract][Full Text] [Related]
15. LEVELS OF PROINFLAMMATORY CYTOKINES IL-17 AND IL-23 IN PATIENTS WITH ALZHEIMER'S DISEASE, MILD COGNITIVE IMPAIRMENT AND VASCULAR DEMENTIA.
Dubenko OE; Chyniak OS; Potapov OO
Wiad Lek; 2021; 74(1):68-71. PubMed ID: 33851590
[TBL] [Abstract][Full Text] [Related]
16. Interventions for heart disease and their effects on Alzheimer's disease.
Wolozin B; Bednar MM
Neurol Res; 2006 Sep; 28(6):630-6. PubMed ID: 16945215
[TBL] [Abstract][Full Text] [Related]
17. Joint space-time Bayesian disease mapping via quantification of disease risk association.
Baer DR; Lawson AB; Joseph JE
Stat Methods Med Res; 2021 Jan; 30(1):35-61. PubMed ID: 33595403
[TBL] [Abstract][Full Text] [Related]
18. Landscape of immune infiltration in entorhinal cortex of patients with Alzheimer's disease.
Zhang H; Cao S; Xu Y; Sun X; Fei M; Jing Q; Xu X; Tang J; Niu B; Li C
Front Pharmacol; 2022; 13():941656. PubMed ID: 36249779
[TBL] [Abstract][Full Text] [Related]
19. Emerging roles of astrocytes in blood-brain barrier disruption upon amyloid-beta insults in Alzheimer's disease.
Yue Q; Hoi MPM
Neural Regen Res; 2023 Sep; 18(9):1890-1902. PubMed ID: 36926705
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
